If recovery of function is complete and a normal glomerular filtration rate is re-established with no evidence of residual renal injury, no renal follow-up is required.
If the patient is left with residual chronic kidney disease (CKD) after AKI, nephrologist follow-up is recommended with interventions based on stage of CKD.
The National Kidney Foundation KDOQI guidelines include recommendations regarding the management of patients who have developed CKD subsequent to AKI. Management of chronic intrinsic renal diseases (e.g., glomerulonephritis and vasculitis) requires nephrologist intervention to manage therapies including corticosteroids, cytotoxic drugs, and immune-modifying drugs. Adverse effects and toxicities require close observation.
Use of this content is subject to our disclaimer